242 related articles for article (PubMed ID: 23832079)
1. A myostatin inhibitor (propeptide-Fc) increases muscle mass and muscle fiber size in aged mice but does not increase bone density or bone strength.
Arounleut P; Bialek P; Liang LF; Upadhyay S; Fulzele S; Johnson M; Elsalanty M; Isales CM; Hamrick MW
Exp Gerontol; 2013 Sep; 48(9):898-904. PubMed ID: 23832079
[TBL] [Abstract][Full Text] [Related]
2. Recombinant myostatin (GDF-8) propeptide enhances the repair and regeneration of both muscle and bone in a model of deep penetrant musculoskeletal injury.
Hamrick MW; Arounleut P; Kellum E; Cain M; Immel D; Liang LF
J Trauma; 2010 Sep; 69(3):579-83. PubMed ID: 20173658
[TBL] [Abstract][Full Text] [Related]
3. A myostatin and activin decoy receptor enhances bone formation in mice.
Bialek P; Parkington J; Li X; Gavin D; Wallace C; Zhang J; Root A; Yan G; Warner L; Seeherman HJ; Yaworsky PJ
Bone; 2014 Mar; 60():162-71. PubMed ID: 24333131
[TBL] [Abstract][Full Text] [Related]
4. A GDF11/myostatin inhibitor, GDF11 propeptide-Fc, increases skeletal muscle mass and improves muscle strength in dystrophic mdx mice.
Jin Q; Qiao C; Li J; Xiao B; Li J; Xiao X
Skelet Muscle; 2019 May; 9(1):16. PubMed ID: 31133057
[TBL] [Abstract][Full Text] [Related]
5. Myostatin deficiency partially rescues the bone phenotype of osteogenesis imperfecta model mice.
Oestreich AK; Carleton SM; Yao X; Gentry BA; Raw CE; Brown M; Pfeiffer FM; Wang Y; Phillips CL
Osteoporos Int; 2016 Jan; 27(1):161-70. PubMed ID: 26179666
[TBL] [Abstract][Full Text] [Related]
6. Antibody-directed myostatin inhibition in 21-mo-old mice reveals novel roles for myostatin signaling in skeletal muscle structure and function.
Murphy KT; Koopman R; Naim T; Léger B; Trieu J; Ibebunjo C; Lynch GS
FASEB J; 2010 Nov; 24(11):4433-42. PubMed ID: 20624929
[TBL] [Abstract][Full Text] [Related]
7. Propeptide-mediated inhibition of myostatin increases muscle mass through inhibiting proteolytic pathways in aged mice.
Collins-Hooper H; Sartori R; Macharia R; Visanuvimol K; Foster K; Matsakas A; Flasskamp H; Ray S; Dash PR; Sandri M; Patel K
J Gerontol A Biol Sci Med Sci; 2014 Sep; 69(9):1049-59. PubMed ID: 24414825
[TBL] [Abstract][Full Text] [Related]
8. Treatment with soluble activin type IIB-receptor improves bone mass and strength in a mouse model of Duchenne muscular dystrophy.
Puolakkainen T; Ma H; Kainulainen H; Pasternack A; Rantalainen T; Ritvos O; Heikinheimo K; Hulmi JJ; Kiviranta R
BMC Musculoskelet Disord; 2017 Jan; 18(1):20. PubMed ID: 28103859
[TBL] [Abstract][Full Text] [Related]
9. Molecular, cellular and physiological investigation of myostatin propeptide-mediated muscle growth in adult mice.
Matsakas A; Foster K; Otto A; Macharia R; Elashry MI; Feist S; Graham I; Foster H; Yaworsky P; Walsh F; Dickson G; Patel K
Neuromuscul Disord; 2009 Jul; 19(7):489-99. PubMed ID: 19541486
[TBL] [Abstract][Full Text] [Related]
10. Increased muscle force production and bone mineral density in ActRIIB-Fc-treated mature rodents.
Chiu CS; Peekhaus N; Weber H; Adamski S; Murray EM; Zhang HZ; Zhao JZ; Ernst R; Lineberger J; Huang L; Hampton R; Arnold BA; Vitelli S; Hamuro L; Wang WR; Wei N; Dillon GM; Miao J; Alves SE; Glantschnig H; Wang F; Wilkinson HA
J Gerontol A Biol Sci Med Sci; 2013 Oct; 68(10):1181-92. PubMed ID: 23525481
[TBL] [Abstract][Full Text] [Related]
11. Muscle-bone interactions in dystrophin-deficient and myostatin-deficient mice.
Montgomery E; Pennington C; Isales CM; Hamrick MW
Anat Rec A Discov Mol Cell Evol Biol; 2005 Sep; 286(1):814-22. PubMed ID: 16078270
[TBL] [Abstract][Full Text] [Related]
12. Increased muscle mass with myostatin deficiency improves gains in bone strength with exercise.
Hamrick MW; Samaddar T; Pennington C; McCormick J
J Bone Miner Res; 2006 Mar; 21(3):477-83. PubMed ID: 16491296
[TBL] [Abstract][Full Text] [Related]
13. A mouse anti-myostatin antibody increases muscle mass and improves muscle strength and contractility in the mdx mouse model of Duchenne muscular dystrophy and its humanized equivalent, domagrozumab (PF-06252616), increases muscle volume in cynomolgus monkeys.
St Andre M; Johnson M; Bansal PN; Wellen J; Robertson A; Opsahl A; Burch PM; Bialek P; Morris C; Owens J
Skelet Muscle; 2017 Nov; 7(1):25. PubMed ID: 29121992
[TBL] [Abstract][Full Text] [Related]
14. Anti-myostatin antibody increases muscle mass and strength and improves insulin sensitivity in old mice.
Camporez JP; Petersen MC; Abudukadier A; Moreira GV; Jurczak MJ; Friedman G; Haqq CM; Petersen KF; Shulman GI
Proc Natl Acad Sci U S A; 2016 Feb; 113(8):2212-7. PubMed ID: 26858428
[TBL] [Abstract][Full Text] [Related]
15. Sarcopenia and fragility fractures: molecular and clinical evidence of the bone-muscle interaction.
Tarantino U; Piccirilli E; Fantini M; Baldi J; Gasbarra E; Bei R
J Bone Joint Surg Am; 2015 Mar; 97(5):429-37. PubMed ID: 25740034
[TBL] [Abstract][Full Text] [Related]
16. Testosterone supplementation reverses sarcopenia in aging through regulation of myostatin, c-Jun NH2-terminal kinase, Notch, and Akt signaling pathways.
Kovacheva EL; Hikim AP; Shen R; Sinha I; Sinha-Hikim I
Endocrinology; 2010 Feb; 151(2):628-38. PubMed ID: 20022929
[TBL] [Abstract][Full Text] [Related]
17. Adeno-associated virus-8-mediated intravenous transfer of myostatin propeptide leads to systemic functional improvements of slow but not fast muscle.
Foster K; Graham IR; Otto A; Foster H; Trollet C; Yaworsky PJ; Walsh FS; Bickham D; Curtin NA; Kawar SL; Patel K; Dickson G
Rejuvenation Res; 2009 Apr; 12(2):85-94. PubMed ID: 19405813
[TBL] [Abstract][Full Text] [Related]
18. Immunolocalization of myostatin (GDF-8) following musculoskeletal injury and the effects of exogenous myostatin on muscle and bone healing.
Elkasrawy M; Immel D; Wen X; Liu X; Liang LF; Hamrick MW
J Histochem Cytochem; 2012 Jan; 60(1):22-30. PubMed ID: 22205678
[TBL] [Abstract][Full Text] [Related]
19. Myostatin and sarcopenia: opportunities and challenges - a mini-review.
White TA; LeBrasseur NK
Gerontology; 2014; 60(4):289-93. PubMed ID: 24457615
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of substance P signaling aggravates the bone loss in ovariectomy-induced osteoporosis.
Zheng XF; Zhao ED; He JY; Zhang YH; Jiang SD; Jiang LS
Prog Biophys Mol Biol; 2016 Nov; 122(2):112-121. PubMed ID: 27237582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
